← All trials
NCT06658964
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 5, 2024
- Primary completion
- Dec 10, 2024
- Completion date
- Mar 21, 2025
- First posted
- Oct 26, 2024
- Last posted
- Oct 26, 2024
- Enrollment
- 48
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- JemincareLead sponsor
- Government of ChinaCollaborator
- Shanghai University of Traditional Chinese MedicineOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.